British 8.832893
ĠBi 8.824033
otech 0.73166704
's 3.6027248
ĠMar 8.7237625
im 4.181749
ast 0.04884961
at 0.014259345
Ġanti 6.3216968
- 0.051993858
cancer 0.25991067
Ġtreatment 3.477512
Ġto 4.8802967
Ġbe 0.58244276
Ġreviewed 4.3139615
Ġat 4.4271865
ĠES 6.3175287
MO 0.027101744
Ġconference 3.4264052
Ġin 1.9518408
ĠVienna 2.983676
Ġ 10.055542
Ċ 5.1786733
Ċ 0.18048482
British 0.7293515
ĠBi 0.009885692
otech 0.0031604832
, 3.1439095
Ġa 0.85891014
Ġleading 2.1703775
ĠUK 1.0727706
Ġbi 1.3919371
otechnology 0.35878083
Ġcompany 0.07573815
, 0.41991812
Ġannounced 1.581241
Ġtoday 0.69086117
Ġthat 0.10989671
Ġupdated 9.367491
Ġresults 1.5461684
Ġfrom 0.31526893
Ġits 1.1626946
ĠPhase 0.97664464
ĠIII 0.84234446
Ġclinical 1.2847773
Ġtrial 0.27526644
Ġof 0.4072393
ĠMar 0.4324082
im 0.0003496548
ast 0.0011920412
at 0.00041327655
, 0.91595113
Ġan 1.4393736
Ġinvestig 3.6386409
ational 0.0015296832
Ġanti 0.43637305
- 0.0041407454
cancer 0.011896487
Ġdrug 1.028378
, 0.43932492
Ġwill 0.20746872
Ġbe 0.007302219
Ġpresented 0.05501082
Ġat 0.22487116
Ġthe 0.10783724
ĠEuropean 0.78070635
ĠSociety 0.50775665
Ġfor 0.107110806
ĠMedical 0.0025730012
ĠOn 0.0011619041
c 0.000120481265
ology 0.00013824523
Ġ( 0.19512333
ES 0.0020979738
MO 6.778445e-05
) 0.012459658
Ġannual 3.384089
Ġconference 1.0330945
Ġin 0.3778409
ĠVienna 0.01112188
Ġnext 3.9330122
Ġmonth 1.0974426
. 0.1747513
ĠMar 3.34546
im 0.00075023813
ast 0.0029636614
at 0.00038018255
Ġis 0.52391773
Ġan 2.1841075
Ġorally 2.777059
- 1.2622744
active 0.98588526
Ġmatrix 3.9718952
Ġmet 0.10125323
all 0.006710508
op 0.0059138844
rotein 0.06535192
ase 0.0040674866
Ġ( 0.76127034
M 0.0036680838
MP 9.759038e-05
) 0.09455364
Ġinhibitor 0.059118435
Ġthat 1.5143732
ĠBritish 4.5425076
ĠBi 0.0010161897
otech 9.38949e-05
Ġis 0.9234456
Ġdeveloping 0.06760582
Ġfor 0.5935599
Ġthe 0.3199124
Ġtreatment 0.10222141
Ġof 0.006431817
Ġgastrointestinal 3.7370472
Ġcancers 1.5783448
, 1.5603719
Ġincluding 0.59165186
Ġpancreat 2.9115283
ic 0.0001783078
, 1.3295217
Ġgast 1.4736891
ric 0.00013311833
, 0.999491
Ġand 2.1361263
Ġcol 0.43592158
ore 0.00044642974
ct 3.941184e-05
al 0.00019344824
Ġcancers 0.60778874
. 0.1998948
Ċ 0.6531794
Ċ 0.048341323
The 1.0966285
Ġnew 3.8164039
Ġdata 0.75662506
Ġwill 1.4967244
Ġprovide 3.616963
Ġan 1.3360587
Ġanalysis 3.4065628
Ġof 0.059279192
Ġoverall 1.4184954
Ġsurvival 0.012675196
Ġfrom 3.0247464
Ġthe 0.38504988
Ġdouble 6.1967096
- 0.11196603
blind 0.0015129094
, 0.65257025
Ġplacebo 0.35861892
- 0.18296978
controlled 0.0059159813
Ġtrial 1.8352363
Ġevaluating 5.427111
ĠMar 0.69279355
im 6.4446605e-05
ast 0.0005849042
at 0.00042293806
Ġin 0.6376699
Ġcombination 0.5497991
Ġwith 0.0072507653
Ġgem 1.6612582
cit 0.001291465
ab 0.001233157
ine 0.00012155601
, 1.6794702
Ġa 0.8805892
Ġstandard 1.2196347
Ġchemotherapy 0.89284545
, 3.1748893
Ġin 0.4873272
Ġpatients 0.37128025
Ġwith 0.03178719
Ġadvanced 0.5873913
Ġpancreat 0.37061277
ic 9.56821e-05
Ġcancer 0.039555263
. 0.17507662
ĠPrevious 5.680381
Ġresults 1.456022
Ġfrom 0.65818024
Ġthe 0.44003844
Ġtrial 0.65838945
Ġshowed 1.4891514
Ġthe 4.458837
Ġcombination 0.51974607
Ġsignificantly 2.8754148
Ġimproved 1.0924956
Ġprogression 1.5729517
- 0.23102756
free 0.0023115927
Ġsurvival 0.0108670825
Ġcompared 1.1624228
Ġto 0.4647203
Ġgem 0.13292336
cit 0.004071975
ab 0.00018772435
ine 6.0276172e-05
Ġalone 0.12439268
. 0.48296142
ĠThe 1.7800618
Ġtrial 3.3395655
Ġenrolled 3.4310613
Ġover 3.3885055
Ġ900 4.348606
Ġpatients 0.0581048
Ġacross 2.0915468
Ġ150 5.964286
Ġcenters 2.8119402
Ġin 0.31798422
ĠEurope 2.8888237
, 0.42525297
ĠAustralia 2.6012256
, 0.54700243
ĠCanada 2.8728204
Ġand 0.97798574
Ġthe 1.0407727
ĠUnited 1.4627342
ĠStates 0.003952764
. 0.3300822
Ċ 0.38699657
Ċ 0.03315258
bytes:\xe2\x80 3.0545783
bytes:\x9c 0.032066505
We 1.3990765
Ġare 0.3586114
Ġvery 1.3814584
Ġpleased 0.60538036
Ġto 0.458981
Ġhave 1.5214552
Ġthe 0.82124263
Ġopportunity 0.16834785
Ġto 0.016134113
Ġpresent 0.28499776
Ġthese 2.0335734
Ġimportant 2.0491714
Ġnew 1.7533749
Ġdata 0.60439986
Ġon 1.6849344
Ġoverall 2.6495895
Ġsurvival 0.0041682757
Ġwith 4.3566437
ĠMar 0.21649201
im 4.847264e-05
ast 0.0003632502
at 0.00024704146
Ġat 0.8167687
Ġthe 0.92012256
ĠES 0.15983824
MO 0.00020441732
Ġconference 0.36220613
, 0.6146317
bytes:\xe2\x80 0.14855388
bytes:\x9d 0.0026962918
Ġsaid 0.17425539
ĠDr 1.3645223
. 0.5684106
ĠPeter 3.795796
ĠParker 8.21092
, 0.019806297
ĠChief 1.2120088
ĠMedical 2.4384408
ĠOfficer 0.0066112624
Ġat 1.1992999
ĠBritish 0.008630296
ĠBi 0.0019610801
otech 0.0001562495
. 0.040514246
bytes:Ġ\xe2\x80 0.034901224
bytes:\x9c 0.0015043133
P 3.5662894
anc 0.010394307
reat 0.00016960275
ic 5.216904e-05
Ġcancer 0.020849694
Ġremains 2.8100784
Ġan 1.5902109
Ġarea 1.7887576
Ġof 0.16833276
Ġhigh 2.4128902
Ġun 0.019149361
met 0.0005947469
Ġmedical 0.685985
Ġneed 0.002228373
, 0.89296424
Ġand 0.6130623
Ġwe 0.87083757
Ġbelieve 1.0145413
ĠMar 1.4210951
im 2.880226e-05
ast 0.00041035545
at 6.170386e-05
Ġhas 0.81462425
Ġthe 0.18979856
Ġpotential 0.005374525
Ġto 0.011955845
Ġbecome 2.665879
Ġan 1.224967
Ġimportant 0.1426726
Ġnew 0.58145314
Ġtreatment 0.2894321
Ġoption 0.3681923
Ġfor 0.28625205
Ġpatients 0.42498943
Ġwith 0.67789465
Ġthis 0.59668237
Ġdevastating 1.9809177
Ġdisease 0.05768499
. 0.07870457
bytes:\xe2\x80 0.15746732
bytes:\x9d 0.00030713953
Ċ 0.06730977
Ċ 0.039076224
British 2.8954563
ĠBi 0.0018695327
otech 0.00011511593
Ġalso 3.1879747
Ġplans 3.9014874
Ġto 0.010516396
Ġmeet 4.000147
Ġwith 0.05630702
Ġthe 2.4833274
ĠEuropean 0.82814515
ĠMedic 0.40462273
ines 0.0010561679
ĠAgency 0.008070306
Ġ( 0.3077714
EMA 0.019350734
) 0.03318062
Ġand 2.798864
ĠU 5.423364
. 0.00069148606
S 0.016080206
. 0.004397965
ĠFood 0.025201749
Ġand 0.055357806
ĠDrug 0.0026162693
ĠAdministration 0.0021738939
Ġ( 0.010538022
F 0.0058226315
DA 1.0444119e-05
) 0.01001934
Ġin 1.8141576
Ġthe 1.1906762
Ġcoming 0.6513188
Ġmonths 0.8485652
Ġto 0.15022984
Ġdiscuss 0.17987566
Ġfiling 6.059347
Ġfor 1.8740201
Ġmarketing 0.79982
Ġapproval 0.5469603
Ġof 0.49348053
ĠMar 0.04535812
im 7.601266e-05
ast 0.00022182555
at 0.00023023302
Ġbased 4.28393
Ġon 0.0189501
Ġthe 0.5231344
Ġfinal 5.887303
Ġdata 1.9000045
Ġfrom 0.29558355
Ġthis 1.7042797
Ġtrial 0.7170624
. 0.22741525
ĠMar 3.7042475
im 0.0006347644
ast 0.00040832703
at 0.0005640305
Ġhas 1.2364773
Ġbeen 1.5512377
Ġgranted 0.21824224
ĠOr 1.1429136
phan 3.249586e-05
ĠDrug 0.11004914
Ġstatus 2.2417295
Ġfor 2.0366893
Ġpancreat 1.320743
ic 0.000101643476
Ġcancer 0.08353498
Ġin 0.6055153
Ġboth 0.88255763
Ġthe 0.14552808
ĠEU 2.3742437
Ġand 0.0049445867
ĠU 1.535001
. 4.1678675e-05
S 0.0010309285
. 0.2756223
ĠBritish 4.814613
ĠBi 0.0014099415
otech 6.337372e-05
Ġpreviously 4.129128
Ġreported 2.4585395
Ġthe 4.304733
Ġtrial 4.508072
Ġmet 1.2711601
Ġits 0.23643278
Ġprimary 0.122917846
Ġendpoint 0.20309517
Ġof 0.6542355
Ġprogression 0.85542905
- 0.04217816
free 0.0008606544
Ġsurvival 0.0056638885
, 1.4221693
Ġbut 2.9643502
Ġthe 1.9985341
Ġdata 2.5749426
Ġon 1.4770077
Ġoverall 0.008019113
Ġsurvival 0.002495738
Ġwas 2.7931054
Ġnot 1.2822466
Ġyet 2.3380365
Ġmature 0.36318764
Ġat 1.3687435
Ġthe 0.7392053
Ġtime 0.017959898
Ġof 0.67752403
Ġthat 1.3893712
Ġanalysis 4.2088375
. 0.120411135
Ċ 0.31282893
Ċ 0.021263693
The 2.140156
ĠES 1.8002607
MO 7.040798e-05
Ġannual 2.1675282
Ġconference 0.2554641
Ġis 1.8137598
Ġthe 0.8788783
Ġpre 4.963732
em 0.90810496
inent 3.2906587e-06
ĠEuropean 1.9413234
Ġevent 2.476105
Ġin 1.8711901
Ġon 1.1210515
c 0.0005365965
ology 0.0017192371
, 0.8848602
Ġbringing 2.1996632
Ġtogether 0.042438883
Ġleading 2.8064651
Ġon 1.295848
c 0.00019392508
ology 0.95690095
Ġprofessionals 1.5292143
Ġand 2.1357398
Ġresearchers 1.7756763
Ġfrom 0.5882109
Ġaround 0.49817842
Ġthe 0.0024483511
Ġworld 0.09541292
Ġto 1.3396935
Ġpresent 2.1969736
Ġand 0.5466365
Ġdiscuss 0.092641294
Ġthe 0.5219405
Ġlatest 0.13291493
Ġresearch 2.1676657
Ġfindings 2.6263595
Ġin 1.5442692
Ġclinical 4.989237
Ġon 0.4764976
c 5.4314798e-05
ology 0.0009145874
. 0.6190421
ĠThe 1.2601781
Ġconference 0.7511323
Ġwill 0.8355868
Ġbe 0.81600827
Ġheld 0.030255022
Ġfrom 1.6474845
ĠSeptember 0.9702102
Ġ27 2.8488445
Ġto 0.9924516
ĠOctober 0.20407386
Ġ1 0.12982498
Ġin 1.0358727
ĠVienna 0.019969556
, 0.30946374
ĠAustria 0.036725845
. 0.058356058
